Structure

Physi-Chem Properties

Molecular Weight:  161.05
Volume:  162.502
LogP:  2.127
LogD:  2.021
LogS:  -2.725
# Rotatable Bonds:  1
TPSA:  53.09
# H-Bond Aceptor:  3
# H-Bond Donor:  2
# Rings:  2
# Heavy Atoms:  3

MedChem Properties

QED Drug-Likeness Score:  0.67
Synthetic Accessibility Score:  1.705
Fsp3:  0.0
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.659
MDCK Permeability:  5.7560009736334905e-06
Pgp-inhibitor:  0.0
Pgp-substrate:  0.003
Human Intestinal Absorption (HIA):  0.017
20% Bioavailability (F20%):  0.002
30% Bioavailability (F30%):  0.921

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.548
Plasma Protein Binding (PPB):  68.19196319580078%
Volume Distribution (VD):  0.323
Pgp-substrate:  26.1390380859375%

ADMET: Metabolism

CYP1A2-inhibitor:  0.264
CYP1A2-substrate:  0.119
CYP2C19-inhibitor:  0.094
CYP2C19-substrate:  0.056
CYP2C9-inhibitor:  0.122
CYP2C9-substrate:  0.394
CYP2D6-inhibitor:  0.051
CYP2D6-substrate:  0.163
CYP3A4-inhibitor:  0.028
CYP3A4-substrate:  0.076

ADMET: Excretion

Clearance (CL):  3.567
Half-life (T1/2):  0.904

ADMET: Toxicity

hERG Blockers:  0.065
Human Hepatotoxicity (H-HT):  0.463
Drug-inuced Liver Injury (DILI):  0.908
AMES Toxicity:  0.008
Rat Oral Acute Toxicity:  0.911
Maximum Recommended Daily Dose:  0.025
Skin Sensitization:  0.257
Carcinogencity:  0.086
Eye Corrosion:  0.012
Eye Irritation:  0.987
Respiratory Toxicity:  0.746

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC278434

Natural Product ID:  NPC278434
Common Name*:   Indole-3-Carboxylic Acid
IUPAC Name:   1H-indole-3-carboxylic acid
Synonyms:   Indole-3-Carboxylic Acid
Standard InCHIKey:  KMAKOBLIOCQGJP-UHFFFAOYSA-N
Standard InCHI:  InChI=1S/C9H7NO2/c11-9(12)7-5-10-8-4-2-1-3-6(7)8/h1-5,10H,(H,11,12)
SMILES:  c1ccc2c(c1)c(c[nH]2)C(=O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL387527
PubChem CID:   69867
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0000211] Indoles and derivatives
        • [CHEMONTID:0002013] Indolecarboxylic acids and derivatives

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT153 Individual Protein Androgen Receptor Homo sapiens Inhibition = 1.0 % PMID[534428]
NPT113 Cell Line RAW264.7 Mus musculus IC50 > 10000.0 nM PMID[534431]
NPT27 Others Unspecified LogP app = -6.1 n.a. PMID[534427]
NPT35 Others n.a. LogP = 1.99 n.a. PMID[534427]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. Activity = 0.092 n.a. PMID[534429]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. Activity = -10.1 n.a. PMID[534429]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. Activity = -6.5 n.a. PMID[534429]
NPT20 Organism Candida albicans Candida albicans Inhibition = 6.48 % PMID[534433]
NPT85 Organism Filobasidiella neoformans Cryptococcus neoformans Inhibition = -9.05 % PMID[534433]
NPT19 Organism Escherichia coli Escherichia coli Inhibition = -2.29 % PMID[534433]
NPT173 Organism Klebsiella pneumoniae Klebsiella pneumoniae Inhibition = -9.13 % PMID[534433]
NPT18 Organism Pseudomonas aeruginosa Pseudomonas aeruginosa Inhibition = 16.88 % PMID[534433]
NPT747 Organism Acinetobacter baumannii Acinetobacter baumannii Inhibition = 1.08 % PMID[534433]
NPT2922 Organism Staphylococcus aureus subsp. aureus Staphylococcus aureus subsp. aureus Inhibition = -3.47 % PMID[534433]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC278434 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9364 High Similarity NPC138370
0.9086 High Similarity NPC83111
0.887 High Similarity NPC154339
0.8837 High Similarity NPC111275
0.875 High Similarity NPC282103
0.8722 High Similarity NPC267343
0.871 High Similarity NPC82053
0.8631 High Similarity NPC131718
0.8617 High Similarity NPC171787
0.8596 High Similarity NPC78020
0.8588 High Similarity NPC42372
0.8564 High Similarity NPC183777
0.8557 High Similarity NPC74360
0.8529 High Similarity NPC102423
0.847 Intermediate Similarity NPC202812
0.8466 Intermediate Similarity NPC55772
0.8441 Intermediate Similarity NPC213308
0.8438 Intermediate Similarity NPC219087
0.8432 Intermediate Similarity NPC474916
0.84 Intermediate Similarity NPC203468
0.84 Intermediate Similarity NPC149155
0.84 Intermediate Similarity NPC110500
0.8396 Intermediate Similarity NPC471944
0.8352 Intermediate Similarity NPC267885
0.8295 Intermediate Similarity NPC293216
0.8287 Intermediate Similarity NPC315555
0.8268 Intermediate Similarity NPC71037
0.8258 Intermediate Similarity NPC283219
0.8258 Intermediate Similarity NPC213468
0.8258 Intermediate Similarity NPC126709
0.8258 Intermediate Similarity NPC248041
0.8245 Intermediate Similarity NPC45459
0.8245 Intermediate Similarity NPC315491
0.8239 Intermediate Similarity NPC313791
0.8235 Intermediate Similarity NPC131887
0.8229 Intermediate Similarity NPC266249
0.82 Intermediate Similarity NPC229893
0.8196 Intermediate Similarity NPC82370
0.8182 Intermediate Similarity NPC90229
0.8144 Intermediate Similarity NPC123839
0.8141 Intermediate Similarity NPC276657
0.8138 Intermediate Similarity NPC67288
0.8101 Intermediate Similarity NPC284775
0.8098 Intermediate Similarity NPC221873
0.8087 Intermediate Similarity NPC62749
0.8085 Intermediate Similarity NPC156704
0.8077 Intermediate Similarity NPC477003
0.8066 Intermediate Similarity NPC470677
0.8035 Intermediate Similarity NPC230869
0.8 Intermediate Similarity NPC14113
0.8 Intermediate Similarity NPC145885
0.8 Intermediate Similarity NPC84827
0.799 Intermediate Similarity NPC27041
0.799 Intermediate Similarity NPC472285
0.799 Intermediate Similarity NPC88008
0.7989 Intermediate Similarity NPC235684
0.7978 Intermediate Similarity NPC110158
0.7976 Intermediate Similarity NPC159856
0.7959 Intermediate Similarity NPC309845
0.7943 Intermediate Similarity NPC242116
0.7935 Intermediate Similarity NPC280290
0.7927 Intermediate Similarity NPC98715
0.7926 Intermediate Similarity NPC88315
0.7923 Intermediate Similarity NPC469358
0.791 Intermediate Similarity NPC41717
0.7907 Intermediate Similarity NPC469760
0.7907 Intermediate Similarity NPC259644
0.7907 Intermediate Similarity NPC73952
0.7907 Intermediate Similarity NPC469763
0.7907 Intermediate Similarity NPC469786
0.7907 Intermediate Similarity NPC469765
0.7907 Intermediate Similarity NPC25008
0.7903 Intermediate Similarity NPC321708
0.7884 Intermediate Similarity NPC157828
0.7884 Intermediate Similarity NPC276517
0.7884 Intermediate Similarity NPC195239
0.7876 Intermediate Similarity NPC57398
0.7874 Intermediate Similarity NPC469762
0.7861 Intermediate Similarity NPC75540
0.7861 Intermediate Similarity NPC212376
0.7861 Intermediate Similarity NPC70922
0.7861 Intermediate Similarity NPC211572
0.7861 Intermediate Similarity NPC80597
0.7849 Intermediate Similarity NPC46580
0.7842 Intermediate Similarity NPC11445
0.7838 Intermediate Similarity NPC314002
0.7826 Intermediate Similarity NPC220765
0.7819 Intermediate Similarity NPC476460
0.7816 Intermediate Similarity NPC469785
0.7809 Intermediate Similarity NPC114637
0.7806 Intermediate Similarity NPC225821
0.7806 Intermediate Similarity NPC46225
0.7802 Intermediate Similarity NPC184964
0.7801 Intermediate Similarity NPC227582
0.7801 Intermediate Similarity NPC141454
0.7797 Intermediate Similarity NPC311276
0.7796 Intermediate Similarity NPC160381
0.7791 Intermediate Similarity NPC105818
0.7791 Intermediate Similarity NPC24678
0.779 Intermediate Similarity NPC303225
0.7789 Intermediate Similarity NPC118940
0.7784 Intermediate Similarity NPC204717
0.7784 Intermediate Similarity NPC322644
0.7784 Intermediate Similarity NPC279918
0.7784 Intermediate Similarity NPC207851
0.7778 Intermediate Similarity NPC302647
0.7772 Intermediate Similarity NPC191415
0.7772 Intermediate Similarity NPC264285
0.7766 Intermediate Similarity NPC127677
0.7766 Intermediate Similarity NPC258062
0.7765 Intermediate Similarity NPC314372
0.7762 Intermediate Similarity NPC182222
0.776 Intermediate Similarity NPC164340
0.7759 Intermediate Similarity NPC33229
0.7751 Intermediate Similarity NPC190296
0.7751 Intermediate Similarity NPC207686
0.774 Intermediate Similarity NPC282231
0.7732 Intermediate Similarity NPC300183
0.773 Intermediate Similarity NPC48938
0.773 Intermediate Similarity NPC102755
0.7705 Intermediate Similarity NPC219848
0.7705 Intermediate Similarity NPC96890
0.7701 Intermediate Similarity NPC171171
0.7684 Intermediate Similarity NPC67551
0.768 Intermediate Similarity NPC273532
0.768 Intermediate Similarity NPC252338
0.7673 Intermediate Similarity NPC36405
0.7663 Intermediate Similarity NPC256268
0.7661 Intermediate Similarity NPC167400
0.7656 Intermediate Similarity NPC179701
0.7653 Intermediate Similarity NPC134848
0.7653 Intermediate Similarity NPC165599
0.765 Intermediate Similarity NPC72956
0.7647 Intermediate Similarity NPC311282
0.7644 Intermediate Similarity NPC326422
0.7644 Intermediate Similarity NPC304203
0.7638 Intermediate Similarity NPC271862
0.7634 Intermediate Similarity NPC243058
0.7629 Intermediate Similarity NPC293917
0.7626 Intermediate Similarity NPC244741
0.7626 Intermediate Similarity NPC193238
0.7621 Intermediate Similarity NPC16352
0.7617 Intermediate Similarity NPC74153
0.7617 Intermediate Similarity NPC272483
0.7617 Intermediate Similarity NPC262898
0.7614 Intermediate Similarity NPC141353
0.7612 Intermediate Similarity NPC471194
0.7612 Intermediate Similarity NPC471193
0.7612 Intermediate Similarity NPC151976
0.7612 Intermediate Similarity NPC6865
0.7612 Intermediate Similarity NPC153980
0.7612 Intermediate Similarity NPC110182
0.7612 Intermediate Similarity NPC87856
0.7611 Intermediate Similarity NPC49954
0.7611 Intermediate Similarity NPC54988
0.7611 Intermediate Similarity NPC160105
0.7611 Intermediate Similarity NPC474561
0.7609 Intermediate Similarity NPC183662
0.7609 Intermediate Similarity NPC217372
0.7609 Intermediate Similarity NPC15573
0.7604 Intermediate Similarity NPC178858
0.7602 Intermediate Similarity NPC476874
0.7602 Intermediate Similarity NPC476073
0.7598 Intermediate Similarity NPC40779
0.7594 Intermediate Similarity NPC228835
0.7592 Intermediate Similarity NPC99666
0.7592 Intermediate Similarity NPC47190
0.7574 Intermediate Similarity NPC267965
0.7574 Intermediate Similarity NPC229348
0.7573 Intermediate Similarity NPC2395
0.7569 Intermediate Similarity NPC63751
0.7568 Intermediate Similarity NPC276540
0.7568 Intermediate Similarity NPC219336
0.7568 Intermediate Similarity NPC233050
0.7568 Intermediate Similarity NPC42979
0.7568 Intermediate Similarity NPC11126
0.7565 Intermediate Similarity NPC472293
0.756 Intermediate Similarity NPC114310
0.7556 Intermediate Similarity NPC115232
0.7554 Intermediate Similarity NPC224764
0.7552 Intermediate Similarity NPC473821
0.7548 Intermediate Similarity NPC476818
0.7542 Intermediate Similarity NPC214106
0.7541 Intermediate Similarity NPC314603
0.7538 Intermediate Similarity NPC477004
0.7538 Intermediate Similarity NPC270918
0.753 Intermediate Similarity NPC194541
0.7528 Intermediate Similarity NPC135141
0.7528 Intermediate Similarity NPC92796
0.7513 Intermediate Similarity NPC90415
0.7513 Intermediate Similarity NPC94752
0.75 Intermediate Similarity NPC132211
0.75 Intermediate Similarity NPC279189
0.75 Intermediate Similarity NPC39679
0.75 Intermediate Similarity NPC203635
0.75 Intermediate Similarity NPC200553
0.75 Intermediate Similarity NPC472292
0.75 Intermediate Similarity NPC96102
0.75 Intermediate Similarity NPC204491
0.75 Intermediate Similarity NPC471192

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC278434 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8804 High Similarity NPD2121 Clinical (unspecified phase)
0.8617 High Similarity NPD2509 Approved
0.8617 High Similarity NPD2510 Approved
0.8556 High Similarity NPD5901 Discontinued
0.84 Intermediate Similarity NPD482 Approved
0.8371 Intermediate Similarity NPD3178 Discontinued
0.8352 Intermediate Similarity NPD749 Clinical (unspecified phase)
0.8308 Intermediate Similarity NPD3393 Approved
0.8308 Intermediate Similarity NPD3389 Approved
0.8308 Intermediate Similarity NPD3394 Approved
0.8278 Intermediate Similarity NPD2091 Phase 2
0.8278 Intermediate Similarity NPD2096 Phase 2
0.8245 Intermediate Similarity NPD484 Approved
0.8242 Intermediate Similarity NPD4948 Discontinued
0.8222 Intermediate Similarity NPD2092 Phase 2
0.8222 Intermediate Similarity NPD2094 Phase 2
0.8222 Intermediate Similarity NPD2095 Phase 2
0.8122 Intermediate Similarity NPD5728 Clinical (unspecified phase)
0.8034 Intermediate Similarity NPD750 Phase 2
0.7989 Intermediate Similarity NPD5065 Approved
0.7958 Intermediate Similarity NPD8248 Clinical (unspecified phase)
0.7828 Intermediate Similarity NPD5475 Discontinued
0.7795 Intermediate Similarity NPD6987 Phase 1
0.7789 Intermediate Similarity NPD5975 Clinical (unspecified phase)
0.7755 Intermediate Similarity NPD4862 Clinical (unspecified phase)
0.775 Intermediate Similarity NPD3795 Approved
0.775 Intermediate Similarity NPD3794 Approved
0.7722 Intermediate Similarity NPD1573 Approved
0.7722 Intermediate Similarity NPD1575 Approved
0.7716 Intermediate Similarity NPD6838 Clinical (unspecified phase)
0.7714 Intermediate Similarity NPD276 Clinical (unspecified phase)
0.7704 Intermediate Similarity NPD3947 Discontinued
0.77 Intermediate Similarity NPD8093 Discontinued
0.7688 Intermediate Similarity NPD7998 Clinical (unspecified phase)
0.7667 Intermediate Similarity NPD2844 Phase 3
0.7662 Intermediate Similarity NPD8094 Discontinued
0.7661 Intermediate Similarity NPD9075 Approved
0.7661 Intermediate Similarity NPD9074 Approved
0.765 Intermediate Similarity NPD7470 Discontinued
0.7632 Intermediate Similarity NPD5592 Clinical (unspecified phase)
0.7629 Intermediate Similarity NPD7621 Clinical (unspecified phase)
0.7598 Intermediate Similarity NPD1631 Approved
0.7594 Intermediate Similarity NPD3607 Clinical (unspecified phase)
0.7577 Intermediate Similarity NPD4987 Clinical (unspecified phase)
0.7568 Intermediate Similarity NPD5398 Clinical (unspecified phase)
0.7563 Intermediate Similarity NPD6176 Phase 1
0.756 Intermediate Similarity NPD4845 Discontinued
0.7539 Intermediate Similarity NPD6180 Clinical (unspecified phase)
0.7539 Intermediate Similarity NPD2336 Approved
0.7527 Intermediate Similarity NPD4184 Clinical (unspecified phase)
0.7525 Intermediate Similarity NPD5426 Phase 3
0.7524 Intermediate Similarity NPD6242 Discontinued
0.7513 Intermediate Similarity NPD4426 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD198 Clinical (unspecified phase)
0.7461 Intermediate Similarity NPD5575 Clinical (unspecified phase)
0.7461 Intermediate Similarity NPD1173 Approved
0.7449 Intermediate Similarity NPD6999 Discontinued
0.7449 Intermediate Similarity NPD7000 Clinical (unspecified phase)
0.744 Intermediate Similarity NPD3280 Approved
0.7438 Intermediate Similarity NPD3917 Approved
0.7438 Intermediate Similarity NPD3918 Approved
0.7438 Intermediate Similarity NPD3916 Clinical (unspecified phase)
0.7438 Intermediate Similarity NPD6657 Clinical (unspecified phase)
0.7432 Intermediate Similarity NPD1326 Approved
0.7432 Intermediate Similarity NPD1325 Approved
0.743 Intermediate Similarity NPD1630 Approved
0.7427 Intermediate Similarity NPD107 Approved
0.7416 Intermediate Similarity NPD3222 Phase 2
0.7415 Intermediate Similarity NPD6733 Discontinued
0.7403 Intermediate Similarity NPD5140 Approved
0.7403 Intermediate Similarity NPD5138 Approved
0.74 Intermediate Similarity NPD2715 Clinical (unspecified phase)
0.7394 Intermediate Similarity NPD1783 Clinical (unspecified phase)
0.7389 Intermediate Similarity NPD3915 Approved
0.7385 Intermediate Similarity NPD2307 Discontinued
0.7384 Intermediate Similarity NPD1592 Phase 3
0.7377 Intermediate Similarity NPD5069 Clinical (unspecified phase)
0.7371 Intermediate Similarity NPD1038 Approved
0.7371 Intermediate Similarity NPD802 Phase 2
0.7368 Intermediate Similarity NPD786 Approved
0.7353 Intermediate Similarity NPD8096 Phase 3
0.7353 Intermediate Similarity NPD8097 Phase 3
0.735 Intermediate Similarity NPD2721 Clinical (unspecified phase)
0.735 Intermediate Similarity NPD6323 Clinical (unspecified phase)
0.7347 Intermediate Similarity NPD5003 Discontinued
0.7347 Intermediate Similarity NPD7948 Phase 1
0.7343 Intermediate Similarity NPD7878 Phase 2
0.7337 Intermediate Similarity NPD8073 Approved
0.7327 Intermediate Similarity NPD7947 Clinical (unspecified phase)
0.7326 Intermediate Similarity NPD2144 Approved
0.7324 Intermediate Similarity NPD5801 Clinical (unspecified phase)
0.732 Intermediate Similarity NPD6665 Discontinued
0.7315 Intermediate Similarity NPD3006 Discontinued
0.7313 Intermediate Similarity NPD6732 Clinical (unspecified phase)
0.7313 Intermediate Similarity NPD7001 Phase 3
0.7308 Intermediate Similarity NPD7404 Approved
0.7306 Intermediate Similarity NPD4499 Approved
0.73 Intermediate Similarity NPD8072 Approved
0.7296 Intermediate Similarity NPD4848 Phase 1
0.7283 Intermediate Similarity NPD1722 Approved
0.7273 Intermediate Similarity NPD6137 Clinical (unspecified phase)
0.7268 Intermediate Similarity NPD6630 Clinical (unspecified phase)
0.7264 Intermediate Similarity NPD944 Approved
0.726 Intermediate Similarity NPD8405 Clinical (unspecified phase)
0.7249 Intermediate Similarity NPD6595 Phase 3
0.7249 Intermediate Similarity NPD1291 Clinical (unspecified phase)
0.7231 Intermediate Similarity NPD3404 Approved
0.7231 Intermediate Similarity NPD4922 Phase 2
0.7231 Intermediate Similarity NPD5505 Discontinued
0.723 Intermediate Similarity NPD6165 Phase 2
0.723 Intermediate Similarity NPD6164 Phase 2
0.7228 Intermediate Similarity NPD2008 Discontinued
0.7228 Intermediate Similarity NPD7010 Phase 3
0.7225 Intermediate Similarity NPD1096 Discontinued
0.7225 Intermediate Similarity NPD6178 Phase 3
0.7217 Intermediate Similarity NPD7269 Clinical (unspecified phase)
0.7216 Intermediate Similarity NPD2564 Approved
0.7216 Intermediate Similarity NPD2565 Phase 2
0.7211 Intermediate Similarity NPD3038 Discontinued
0.7209 Intermediate Similarity NPD203 Clinical (unspecified phase)
0.7209 Intermediate Similarity NPD2896 Discontinued
0.7206 Intermediate Similarity NPD4506 Discontinued
0.7198 Intermediate Similarity NPD5293 Phase 2
0.7198 Intermediate Similarity NPD8112 Clinical (unspecified phase)
0.7196 Intermediate Similarity NPD1587 Approved
0.7196 Intermediate Similarity NPD4076 Approved
0.7196 Intermediate Similarity NPD4079 Approved
0.7191 Intermediate Similarity NPD4462 Approved
0.7191 Intermediate Similarity NPD4463 Approved
0.719 Intermediate Similarity NPD1996 Discontinued
0.7184 Intermediate Similarity NPD1625 Approved
0.7175 Intermediate Similarity NPD9271 Approved
0.7174 Intermediate Similarity NPD1568 Clinical (unspecified phase)
0.7171 Intermediate Similarity NPD7825 Clinical (unspecified phase)
0.7167 Intermediate Similarity NPD5257 Clinical (unspecified phase)
0.7165 Intermediate Similarity NPD1534 Approved
0.7158 Intermediate Similarity NPD2479 Phase 3
0.7158 Intermediate Similarity NPD2481 Approved
0.7157 Intermediate Similarity NPD7618 Phase 3
0.7157 Intermediate Similarity NPD7619 Phase 3
0.7157 Intermediate Similarity NPD7666 Phase 3
0.7157 Intermediate Similarity NPD7665 Phase 2
0.7143 Intermediate Similarity NPD3506 Approved
0.7143 Intermediate Similarity NPD3505 Approved
0.7136 Intermediate Similarity NPD8013 Clinical (unspecified phase)
0.7121 Intermediate Similarity NPD7818 Clinical (unspecified phase)
0.712 Intermediate Similarity NPD5088 Discontinued
0.7115 Intermediate Similarity NPD7970 Approved
0.7115 Intermediate Similarity NPD3757 Clinical (unspecified phase)
0.7115 Intermediate Similarity NPD7971 Clinical (unspecified phase)
0.7109 Intermediate Similarity NPD5827 Discontinued
0.7107 Intermediate Similarity NPD1304 Clinical (unspecified phase)
0.7105 Intermediate Similarity NPD8304 Clinical (unspecified phase)
0.7103 Intermediate Similarity NPD7603 Discontinued
0.7101 Intermediate Similarity NPD7594 Clinical (unspecified phase)
0.7095 Intermediate Similarity NPD5632 Approved
0.7083 Intermediate Similarity NPD3320 Approved
0.7083 Intermediate Similarity NPD3318 Approved
0.7083 Intermediate Similarity NPD3319 Phase 1
0.7079 Intermediate Similarity NPD4702 Approved
0.7079 Intermediate Similarity NPD4703 Approved
0.7077 Intermediate Similarity NPD8110 Clinical (unspecified phase)
0.7068 Intermediate Similarity NPD5473 Discontinued
0.7067 Intermediate Similarity NPD3243 Approved
0.7065 Intermediate Similarity NPD2305 Discontinued
0.7064 Intermediate Similarity NPD5040 Clinical (unspecified phase)
0.7062 Intermediate Similarity NPD6770 Approved
0.7062 Intermediate Similarity NPD706 Phase 1
0.7059 Intermediate Similarity NPD2921 Clinical (unspecified phase)
0.7059 Intermediate Similarity NPD7958 Clinical (unspecified phase)
0.7059 Intermediate Similarity NPD7957 Phase 1
0.7056 Intermediate Similarity NPD4376 Phase 3
0.7053 Intermediate Similarity NPD5416 Discontinued
0.7053 Intermediate Similarity NPD6203 Clinical (unspecified phase)
0.7048 Intermediate Similarity NPD8406 Clinical (unspecified phase)
0.7047 Intermediate Similarity NPD7564 Discontinued
0.7039 Intermediate Similarity NPD3100 Discontinued
0.7039 Intermediate Similarity NPD6529 Discontinued
0.7039 Intermediate Similarity NPD4374 Clinical (unspecified phase)
0.7037 Intermediate Similarity NPD1586 Approved
0.7031 Intermediate Similarity NPD4383 Clinical (unspecified phase)
0.703 Intermediate Similarity NPD7903 Clinical (unspecified phase)
0.7029 Intermediate Similarity NPD1189 Approved
0.7026 Intermediate Similarity NPD6141 Clinical (unspecified phase)
0.7026 Intermediate Similarity NPD8431 Approved
0.7019 Intermediate Similarity NPD2411 Approved
0.7019 Intermediate Similarity NPD4852 Phase 2
0.7014 Intermediate Similarity NPD4429 Discontinued
0.701 Intermediate Similarity NPD6610 Clinical (unspecified phase)
0.701 Intermediate Similarity NPD8098 Approved
0.701 Intermediate Similarity NPD6138 Clinical (unspecified phase)
0.7009 Intermediate Similarity NPD6173 Approved
0.7005 Intermediate Similarity NPD4051 Discontinued
0.7005 Intermediate Similarity NPD7809 Clinical (unspecified phase)
0.7005 Intermediate Similarity NPD1343 Approved
0.7 Intermediate Similarity NPD4075 Phase 2
0.7 Intermediate Similarity NPD2172 Phase 1
0.7 Intermediate Similarity NPD6664 Approved
0.6995 Remote Similarity NPD4345 Clinical (unspecified phase)
0.6995 Remote Similarity NPD820 Phase 3

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data